Učitavanje...

Modeling the long-acting administration of anti-tuberculosis agents using PBPK – a proof of concept study

SETTING AND OBJECTIVE: Current anti-tuberculosis (TB) formulations necessitate uninterrupted treatment to cure TB, but are characterised by sub-optimal adherence, jeopardising therapeutic efficacy. Long-acting injectable (LAI) formulations or implants could address these associated issues. This stud...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Int J Tuberc Lung Dis
Glavni autori: Rajoli, Rajith KR, Podany, Anthony T., Moss, Darren M, Swindells, Susan, Flexner, Charles, Owen, Andrew, Siccardi, Marco
Format: Artigo
Jezik:Inglês
Izdano: 2018
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6166436/
https://ncbi.nlm.nih.gov/pubmed/29991405
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5588/ijtld.17.0515
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!